<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14454">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02918721</url>
  </required_header>
  <id_info>
    <org_study_id>43CH1504</org_study_id>
    <nct_id>NCT02918721</nct_id>
  </id_info>
  <brief_title>Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds</brief_title>
  <official_title>A Randomised, Multi-center, Subject-blinded and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associated With Correction of Moderate to Severe Nasolabial Folds Using Restylane With and Without Addition of 0.3% Lidocaine Hydrochloride</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Q-Med AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Q-Med AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the pain and safety associated with injections of
      Restylane Lidocaine compared to Restylane using a visual analogue scale.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Difference in Pain (Restylane Lidocaine Side - Restylane Side) as measured by a Visual Analogue Scale(VAS)</measure>
    <time_frame>After Injection on Day of Treatment</time_frame>
    <description>No pain is noted at 0 mm and worst pain is noted at 100 mm</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Nasolabial Fold</condition>
  <arm_group>
    <arm_group_label>Restylane Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Restylane Lidocaine will be injected into one side nasolabial fold on Day 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restylane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Restylane will be injected into the opposite side nasolabial fold on Day 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane Lidocaine</intervention_name>
    <description>Intradermal injection</description>
    <arm_group_label>Restylane Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane</intervention_name>
    <description>Intradermal injection</description>
    <arm_group_label>Restylane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Men or women aged 18 years or older of Chinese origin

          -  Subjects willing to abstain from any other facial plastic surgical or cosmetic
             procedures below the level of the lower orbital rim for the duration of the study

          -  Intent to undergo correction of both nasolabial folds(NLF) with a wrinkle severity in
             Wrinkle Severity Rating Scale(WSRS) of either 3 on both sides or 4 on both sides

        Exclusion Criteria:

          -  Previous use of any permanent (non-biodegradable) or semi-permanent facial tissue
             augmentation therapy or autologous fat below the level of the lower orbital rim

          -  Previous use of any hyaluronic acid based or collagen based biodegradable facial
             tissue augmentation therapy below the level of the lower orbital rim within 12 months
             before treatment

          -  Previous tissue revitalisation treatment with laser or light, mesotherapy
             radiofrequency, chemical peeling or dermabrasion in the midface within 6 months
             before treatment

          -  Scars or deformities, active skin disease, inflammation or related conditions near or
             in the area to be treated

          -  Other condition preventing the subject from entering the study in the Investigator's
             opinion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Q-Med AB</last_name>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 27, 2016</lastchanged_date>
  <firstreceived_date>September 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyaluronic Acid, Nasolabial Fold, Lidocaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
